Utah Medical Products, Inc. (UTMD) is in the business of producing high-quality cost-effective medical devices that are predominantly proprietary, disposable and for hospital use. UTMD groups its sales into four general product categories: obstetrics, comprised of labor and delivery management tools for monitoring fetal and maternal well-being, for reducing risk in performing difficult delivery procedures and for improving clinician and patient safety; gynecology/ electrosurgery/ urology, comprised of tools for gynecological procedures associated primarily with cervical/ uterine disease including LETZ, endometrial tissue sampling, transvaginal uterine sonography, diagnostic laparoscopy, surgical contraception and other MIS procedures; specialty excision and incision tools; conservative urinary incontinence therapy devices; and urology surgical procedure devices; neonatal critical care, comprised of devices that provide developmentally-friendly care to the most critically ill babies, including providing vascular access, enteral feeding, administering vital fluids, oxygen therapy while maintaining a neutral thermal environment, providing protection and assisting in specialized applications; and blood pressure monitoring/ accessories/ other, comprised of specialized components as well as molded parts and assemblies sold on an OEM basis to other companies.

Show more
Type
Public
HQ
Midvale, US
Founded
1978
Size (employees)
173 (est)
Utah Medical Products was founded in 1978 and is headquartered in Midvale, US
Report incorrect company information

Utah Medical Products Office Locations

Utah Medical Products has offices in Athlone and Midvale
Midvale, US (HQ)
7043 S Cottonwood St
Athlone, IE
Dublin Rd
Show all (2)
Report incorrect company information

Utah Medical Products Financials and Metrics

Utah Medical Products Financials

Utah Medical Products's revenue was reported to be $39.30 m in FY, 2016 which is a 2.1% decrease from the previous period.
USD

Revenue (Q1, 2018)

10.9 m

Gross profit (Q1, 2018)

6.9 m

Gross profit margin (Q1, 2018), %

63.6%

Net income (Q1, 2018)

4.1 m

EBIT (Q1, 2018)

5 m

Market capitalization (15-Jun-2018)

404.8 m

Closing share price (15-Jun-2018)

108.5

Cash (31-Mar-2018)

42.9 m
Utah Medical Products's current market capitalization is $404.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

40.5 m41.3 m40.2 m39.3 m

Revenue growth, %

2%(3%)(2%)

EBIT

14.8 m16.2 m15.7 m

EBIT margin, %

37%39%39%
Quarterly
USDQ1, 2018

Revenue

10.9 m

Cost of goods sold

4 m

Gross profit

6.9 m

Gross profit Margin, %

64%
USDQ1, 2018

Cash

42.9 m

Inventories

5.6 m

Current Assets

53.1 m

PP&E

11.8 m
Annual
USDFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

5.5 m4.9 m4 m
Quarterly
USDQ1, 2018

Net Income

4.1 m

Depreciation and Amortization

770 k

Inventories

(303 k)

Accounts Payable

142 k
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics

Utah Medical Products Operating Metrics

FY, 2016

Patents (US)

13

Patents Pending

1

Trademarks

31
Show all operating metrics
Report incorrect company information